EssilorLuxottica Advances with Acquisition of Espansione Group

EssilorLuxottica, the global eyewear and vision care conglomerate, has announced the acquisition of Espansione Group, an Italian company leading in the design and manufacture of non-invasive medical devices internationally patented for treating dry eye syndrome and ocular surface diseases. This strategic move significantly enhances EssilorLuxottica’s med-tech portfolio, particularly in technologies such as photobiomodulation and intense pulsed light used in ophthalmology and dermatology. The acquisition signifies a commitment to elevating standards in eye care and expanding clinical technologies. Espansione Group operates in more than 40 countries and is renowned for its high medical standards. The deal aligns with EssilorLuxottica's strategic goals to improve patient service quality and foster an open, collaborative model in the medical solutions sector. Local regulatory reviews and customary closing conditions still apply.